Literature DB >> 15172118

Hyperbaric oxygen alone or combined with 5-FU attenuates growth of DMBA-induced rat mammary tumors.

Linda E B Stuhr1, Vegard V Iversen, Oddbjørn Straume, Bjørn O Maehle, Rolf K Reed.   

Abstract

We tested the hypothesis that hyperbaric oxygen (HBO) alone and with chemotherapy (5-FU) attenuates tumor growth of DMBA-induced tumors in rats. Six series were performed: (1) Controls (air and vehicle 0.9% NaCl i.p.), (2) 5-FU (0.2 mg/kg i.p.), (3) HBO (2 bar for 90 min and vehicle), (4) HBO and 5-FU, (5) HBO (11 days) and air (next 12 days), (6) HBO (23 days). All treatments were applied on days 1, 4, 7, 10 (Series 1-4), as well as on days 14, 17 and 23 (Series 5-6). Tumor diameter increased by 76.7 and 41.2% in untreated controls and in the 5-FU group, respectively, after 10 days. Tumor size fell by 17-24.2% in the HBO groups and by 35.5% when combined with 5-FU (P < 0.05 compared to HBO). HBO treatment reduced the total number of blood vessels in the tumors. After completion of HBO treatment tumor size increased, but statistically insignificant, during the next 12 days. Copyright 2004 Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15172118     DOI: 10.1016/j.canlet.2004.02.012

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  23 in total

1.  Pericellular pH homeostasis is a primary function of the Warburg effect: inversion of metabolic systems to control lactate steady state in tumor cells.

Authors:  Elizabeth A Mazzio; Nawal Boukli; Nery Rivera; Karam F A Soliman
Journal:  Cancer Sci       Date:  2012-02-14       Impact factor: 6.716

Review 2.  Role of hyperoxic treatment in cancer.

Authors:  Sei W Kim; In K Kim; Sang H Lee
Journal:  Exp Biol Med (Maywood)       Date:  2020-04-23

3.  Raloxifene Inhibits NF-kB Pathway and Potentiates Anti-Tumour Activity of Cisplatin with Simultaneous Reduction in its Nephrotoxictiy.

Authors:  Vinayak Sudhir Jamdade; Nitin A Mundhe; Parveen Kumar; Venkatesh Tadla; Mangala Lahkar
Journal:  Pathol Oncol Res       Date:  2015-10-06       Impact factor: 3.201

Review 4.  Hyperbaric oxygen therapy for malignancy: a review.

Authors:  Jurstine Daruwalla; Chris Christophi
Journal:  World J Surg       Date:  2006-12       Impact factor: 3.352

5.  Simultaneous hyperbaric oxygen therapy during systemic chemotherapy reverses chemotherapy-induced peripheral neuropathy by inhibiting TLR4 and TRPV1 activation in the central and peripheral nervous system.

Authors:  Ping-Ruey Chou; Ching-Yeh Lu; Jung-Yu Kan; Shih-Hung Wang; Jing-Jou Lo; Shu-Hung Huang; Sheng-Hua Wu
Journal:  Support Care Cancer       Date:  2021-05-18       Impact factor: 3.603

6.  Hyperoxic treatment induces mesenchymal-to-epithelial transition in a rat adenocarcinoma model.

Authors:  Ingrid Moen; Anne Margrete Øyan; Karl-Henning Kalland; Karl Johan Tronstad; Lars Andreas Akslen; Martha Chekenya; Per Øystein Sakariassen; Rolf Kåre Reed; Linda Elin Birkhaug Stuhr
Journal:  PLoS One       Date:  2009-07-28       Impact factor: 3.240

7.  Hyperoxia retards growth and induces apoptosis, changes in vascular density and gene expression in transplanted gliomas in nude rats.

Authors:  Linda Elin Birkhaug Stuhr; A Raa; A M Oyan; K H Kalland; P O Sakariassen; K Petersen; R Bjerkvig; R K Reed
Journal:  J Neurooncol       Date:  2007-06-08       Impact factor: 4.130

8.  Hyperbaric oxygen suppressed tumor progression through the improvement of tumor hypoxia and induction of tumor apoptosis in A549-cell-transferred lung cancer.

Authors:  Shao-Yuan Chen; Koichi Tsuneyama; Mao-Hsiung Yen; Jiunn-Tay Lee; Jiun-Liang Chen; Shih-Ming Huang
Journal:  Sci Rep       Date:  2021-06-08       Impact factor: 4.379

9.  Hyperoxia resensitizes chemoresistant human glioblastoma cells to temozolomide.

Authors:  Stella Sun; Derek Lee; Nikki P Lee; Jenny K S Pu; Stanley T S Wong; W M Lui; C F Fung; Gilberto K K Leung
Journal:  J Neurooncol       Date:  2012-07-05       Impact factor: 4.130

10.  Hyperoxia increases the uptake of 5-fluorouracil in mammary tumors independently of changes in interstitial fluid pressure and tumor stroma.

Authors:  Ingrid Moen; Karl J Tronstad; Odd Kolmannskog; Gerd S Salvesen; Rolf K Reed; Linda E B Stuhr
Journal:  BMC Cancer       Date:  2009-12-17       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.